Cardinal Health (CAH) tumbled to the bottom of the S&P 500 today after agreeing to buy Medtronic’s (MDT) medical supplies business for $6.1 billion and offering disappointing guidance.
Getty ImagesCardinal Health�dropped 12% to $72.39 at 4:30 p.m. today, while the S&P 500 declined 0.3% to 2,342.19. Medtronic finished little changed at $80.33.
Leerink’s David Larsen and Matt Dellelo argue that a “great” deal couldn’t offset the dreary guidance:
This morning CAH lowered FY17 expectations saying EPS is now expected to be at the low end of the guided range and the company announced an acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutruitional Insufficiency businesses for $6.1B. Management also gave preliminary FY18 and FY19 guidance, where EPS is expected to be flat to down mid-single digits and up high single digits, respectively, both of which are below Street expectations. While the deal looks strategically and financially sensible, it is likely not enough to offset the ongoing generic deflation headwinds in Pharmaceutical.
Top 5 Medical Stocks To Invest In 2019: Lifeway Foods, Inc.(LWAY)
Advisors' Opinion:- [By Logan Wallace]
Lifeway Foods (NASDAQ:LWAY) was downgraded by equities research analysts at TheStreet from a “c-” rating to a “d” rating in a report released on Friday.
- [By Joseph Griffin]
Lifeway Foods, Inc. (NASDAQ:LWAY) COO Edward Smolyansky sold 4,890 shares of the company’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $6.41, for a total value of $31,344.90. Following the sale, the chief operating officer now owns 993,614 shares in the company, valued at approximately $6,369,065.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Top 5 Medical Stocks To Invest In 2019: Briggs & Stratton Corporation(BGG)
Advisors' Opinion:- [By ]
For his "Executive Decision" segment, Cramer spoke with Todd Teske, chairman, president and CEO of Briggs & Stratton (BGG) , the small-engine maker that posted a penny-a-share earnings beat on Wednesday, but saw shares fall 11% on lighter-than-expected revenues and a cut in the company's full-year guidance.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Losers Check-Cap Ltd. (NASDAQ: CHEK) fell 23.3 percent to $9.87 in pre-market trading after declining 13.45 percent on Wednesday. SunCoke Energy Partners, L.P. (NYSE: SXCP) fell 12.8 percent to $16.00 in pre-market trading after reporting Q1 results. Briggs & Stratton Corporation (NYSE: BGG) fell 11 percent to $17.55 in pre-market trading after the company posted mixed Q3 results and lowered its FY18 guidance. New Gold Inc. (NYSE: NGD) fell 8.4 percent to $2.30 in pre-market trading following downbeat Q1 results. Quality Care Properties, Inc. (NYSE: QCP) fell 8.2 percent to $20.85 in pre-market trading. Welltower announced plans to acquire QCP for $20.75 per share in cash. China Customer Relations Centers Inc. (NASDAQ: CCRC) shares fell 7.5 percent to $17.25 in pre-market trading after climbing 18.73 percent on Wednesday. Nokia Corporation (NYSE: NOK) shares fell 5.7 percent to $5.58 in pre-market trading after reporting Q1 results. eBay Inc. (NASDAQ: EBAY) fell 5.6 percent to $38.66 in pre-market trading following Q1 results. Southw
Top 5 Medical Stocks To Invest In 2019: Dorman Products, Inc.(DORM)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on Dorman Products (DORM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Dorman Products (DORM)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Honeywell (NYSE: HON) and Dorman Products (NASDAQ:DORM) are both multi-sector conglomerates companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.
Top 5 Medical Stocks To Invest In 2019: Park Hotels & Resorts Inc. (PK)
Advisors' Opinion:- [By Logan Wallace]
Park Hotels & Resorts (NYSE:PK)‘s stock had its “hold” rating reaffirmed by equities researchers at Boenning Scattergood in a research note issued on Monday.
- [By Lee Jackson]
Park Hotels and Resorts Inc. (NYSE: PK) was downgraded to Sell from Neutral at Goldman Sachs. The 52-week trading range for the shares is $23.91 to $32.92. The consensus price target is $30.96. The stock closed Friday at $31.60.
- [By Paul Ausick]
Park Hotels & Resorts Inc. (NYSE: PK) fell about 2.7% Monday to post a new 52-week low of $23.91 after closing at $24.42 on Friday. The 52-week high is $29.93. Volume of more than 4.1million was more than double the daily average. The company announced a secondary offering of nearly 33 million shares along with an additional 4.94 million as an underwriter’s option and a private transaction involving another 15.75 million shares. All shares in the offering are being sold by HNA HLT Holdco I LLC, and none of the proceeds go to Park.
- [By Max Byerly]
Get a free copy of the Zacks research report on Park Hotels & Resorts (PK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Robeco Institutional Asset Management B.V. increased its holdings in Park Hotels & Resorts (NYSE:PK) by 745.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,425 shares of the financial services provider’s stock after purchasing an additional 19,771 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Park Hotels & Resorts were worth $607,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
Get Park Hotels & Resorts alerts: HNA Group secures potential bidders for NH Hotel Group stake (hotelmanagement.net) Reliant Investment Management, LLC Buys Palo Alto Networks Inc, Sells Facebook Inc, Park Hotels & Resorts Inc … (gurufocus.com) Park Hotels & Resorts (PK) Price Target Raised to $34.00 at Barclays (americanbankingnews.com) Park Hotels & Resorts (PK) Coverage Initiated by Analysts at Jefferies Group (americanbankingnews.com) Park Hotels & Resorts (PK) Expected to Post Quarterly Sales of $694.44 Million (americanbankingnews.com)Several brokerages have weighed in on PK. ValuEngine downgraded Park Hotels & Resorts from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd. Barclays increased their price target on Park Hotels & Resorts from $31.00 to $34.00 and gave the stock an “overweight” rating in a research report on Friday. Jefferies Group began coverage on Park Hotels & Resorts in a research report on Thursday. They set a “buy” rating and a $37.00 price target on the stock. Zacks Investment Research raised Park Hotels & Resorts from a “hold” rating to a “buy” rating and set a $34.00 price target on the stock in a research report on Saturday, May 12th. Finally, Boenning Scattergood reaffirmed a “hold” rating on shares of Park Hotels & Resorts in a research report on Monday, May 7th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $34.85.
Top 5 Medical Stocks To Invest In 2019: Deluxe Corporation(DLX)
Advisors' Opinion:- [By Joseph Griffin]
Skyline Asset Management LP bought a new position in shares of Deluxe Co. (NYSE:DLX) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 242,100 shares of the business services provider’s stock, valued at approximately $17,918,000. Skyline Asset Management LP owned approximately 0.51% of Deluxe as of its most recent SEC filing.
- [By Logan Wallace]
Shares of Deluxe Co. (NYSE:DLX) hit a new 52-week high and low during trading on Wednesday . The company traded as low as $66.95 and last traded at $66.64, with a volume of 9122 shares changing hands. The stock had previously closed at $67.67.
- [By Ethan Ryder]
Deluxe Co. (NYSE:DLX) CEO Lee J. Schram sold 6,309 shares of the company’s stock in a transaction dated Monday, June 18th. The shares were sold at an average price of $68.07, for a total transaction of $429,453.63. Following the completion of the sale, the chief executive officer now owns 268,181 shares in the company, valued at approximately $18,255,080.67. The sale was disclosed in a filing with the SEC, which is accessible through this link.
- [By Shane Hupp]
Deluxe Co. (NYSE:DLX) CEO Lee J. Schram sold 691 shares of the firm’s stock in a transaction dated Friday, June 15th. The shares were sold at an average price of $68.12, for a total value of $47,070.92. Following the sale, the chief executive officer now directly owns 268,181 shares in the company, valued at approximately $18,268,489.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
No comments:
Post a Comment